Soft tissue and visceral sarcoma gather a large group of rare to very rare cancers and locally aggressive connective tissue tumours. Novel concepts on histological and molecular classification, optimal management of patients, systemic adjuvant and neoadjuvant treatment have been emerging in the last 5 years. In the present publication, we review and summarise significant changes which impact on disease management in this group of rare cancers.
Keywords: Adjuvant; Expert centres; Molecular classification; Neoadjuvant; Network; Sarcoma; Surgery; Targeted therapies.
Copyright © 2016. Published by Elsevier Ltd.